FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

david staskin

Research Profile

Disorders

Chemicals & Drugs

Physiology

Anatomy

Concepts & Ideas

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Maria Vella; Dudley Robinson; david staskin
A reappraisal of storage and voiding dysfunction.
david staskin; Scott MacDiarmid; Kenneth M Peters; Neal Shore; william chesney de groat
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.
david staskin; Franklin Sun; Zhonghong Guan; Martin C Michel; Jon D Morrow
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of david staskin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maria Vella; Dudley Robinson; david staskin
A reappraisal of storage and voiding dysfunction.
Current urology reports 2012;13(6):482-7.
2012: david staskin; Scott MacDiarmid; Kenneth M Peters; Neal Shore; william chesney de groat
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.
Current urology reports 2012;13(5):327-34.
2012: david staskin; Franklin Sun; Zhonghong Guan; Martin C Michel; Jon D Morrow
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms.
The Journal of urology 2012;187(5):1721-6.
2012: Dudley Robinson; david staskin; Rosa M Laterza; Heinz Koelbl
Defining female voiding dysfunction: ICI-RS 2011.
Neurourology and urodynamics 2012;31(3):313-6.
2011: david staskin; Franklin Sun; Zhonghong Guan; Vik Khullar; Martin C Michel; Jon D Morrow; Roger Dmochowski
Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder.
Neurourology and urodynamics 2011;30(8):1480-5.
2011: david staskin; Andrea Tubaro; Peggy A Norton; James Ashton-Miller
Mechanisms of continence and surgical cure in female and male SUI: surgical research initiatives.
Neurourology and urodynamics 2011;30(5):704-7.
2011: Peter K Sand; Theodore M Johnson Ii; Eric S Rovner; Pamela I Ellsworth; Michael G Oefelein; david staskin
Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
BJU international 2011;107(4):612-20.
2010: david staskin; Gary Kay; Cara Tannenbaum; Howard B Goldman; Kavitha Bhashi; John Ling; Michael G Oefelein
Trospium chloride is undetectable in the older human central nervous system.
Journal of the American Geriatrics Society 2010;58(8):1618-9.
2010: david staskin; G Kay; C Tannenbaum; H B Goldman; K Bhashi; J Ling; M G Oefelein
Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
International journal of clinical practice 2010;64(9):1294-300.
2010: david staskin; S Salvatore
Oxybutynin topical and transdermal formulations: an update.
Drugs of today (Barcelona, Spain : 1998) 2010;46(6):417-25.
2010: Roger R Dmochowski; Jerry M Blaivas; E Ann Gormley; Saad Juma; Mickey M Karram; Deborah J Lightner; Karl M Luber; Eric S Rovner; david staskin; J Christian Winters; Rodney A Appell; Linda E Whetter
Update of AUA guideline on the surgical management of female stress urinary incontinence.
The Journal of urology 2010;183(5):1906-14.
2010: Doreen E Chung; Alexis E Te; david staskin; Steven A Kaplan
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 grams.
Urology 2010;75(5):1144-8.
2010: david staskin; Vik Khullar
Female pelvic surgical devices and techniques need better evidence-based medicine.
Neurourology and urodynamics 2010;29(4):670-5.
2010: david staskin; Martin C Michel; Victor Nitti; Jon D Morrow; Joseph Wang; Zhonghong Guan
Efficacy of fesoterodine over 24 hours in subjects with overactive bladder.
Current medical research and opinion 2010;26(4):813-8.
2010: M T Rosenberg; M M Miner; P A Riley; david staskin
STEP: simplified treatment of the enlarged prostate.
International journal of clinical practice 2010;64(4):488-96.
2010: Linda Cardozo; Vik Khullar; Ahmed El-Tahtawy; Zhonghong Guan; Bimal Malhotra; david staskin
Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder.
BMC urology 2010;10():14.
2010: P Abrams; K E Andersson; L Birder; L Brubaker; L Cardozo; C Chapple; A Cottenden; W Davila; D de Ridder; R Dmochowski; M Drake; C Dubeau; C Fry; P Hanno; J Hay Smith; S Herschorn; G Hosker; C Kelleher; H Koelbl; S Khoury; R Madoff; I Milsom; K Moore; D Newman; V Nitti; C Norton; I Nygaard; C Payne; A Smith; david staskin; S Tekgul; J Thuroff; A Tubaro; D Vodusek; A Wein; J J Wyndaele
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.
Neurourology and urodynamics 2010;29(1):213-40.
2010: Roger R Dmochowski; Kenneth M Peters; Jon D Morrow; Zhonghong Guan; Jason Gong; Franklin Sun; Paul Siami; david staskin
Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder.
Urology 2010;75(1):62-8.
2009: david staskin; Dudley Robinson
Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder.
Expert opinion on pharmacotherapy 2009;10(18):3103-11.
2009: david staskin; M T Rosenberg; P K Sand; N R Zinner; R R Dmochowski
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
International journal of clinical practice 2009;63(12):1715-23.
2009: Linda Cardozo; Christopher Chapple; R Dmochowski; M P Fitzgerald; P Hanno; M C Michel; david staskin; P Van Kerrebroeck; J-J Wyndaele; O Yamaguchi; M Yoshida
Urinary urgency - translating the evidence base into daily clinical practice.
International journal of clinical practice 2009;63(12):1675-82.
2009: david staskin; Michael B Siroky
Re: Benign prostatic obstruction and Parkinson's disease--should transurethral resection of the prostate be avoided? B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler. J Urol 2009; 181: 2209-2213.
The Journal of urology 2009;182(6):2981-2; author reply 2982.
2009: Peter K Sand; Roger R Dmochowski; Norman R Zinner; david staskin; Rodney A Appell
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.
International urogynecology journal and pelvic floor dysfunction 2009;20(12):1431-8.
2009: Linda D Cardozo; Philip E V A Van Kerrebroeck; david staskin
Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.
World journal of urology 2009;27(6):755-63.
2009: david staskin
A call to action: the compelling need to advance the role of urgency.
World journal of urology 2009;27(6):765-6.
2009: david staskin; L Cardozo
Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
International journal of clinical practice 2009;63(6):973-6.
2009: david staskin; Michael G Oefelein
Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-64.
European urology 2009;55(5):e84-5; author reply e86-7.
2009: david staskin; Roger R Dmochowski; Peter K Sand; Scott A Macdiarmid; Kim E Caramelli; Heather Thomas; Gary Hoel
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
The Journal of urology 2009;181(4):1764-72.
2009: david staskin; Michael G Oefelein
Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
European urology 2009;55(3):e49-50; author reply e51.
2008: david staskin
Overactive bladder medication switch studies--vive le différence?
International journal of clinical practice 2008;62(11):1639-40.
2008: david staskin
The five 'Ps' of an incontinence clinical practice guideline.
International journal of clinical practice 2008;62(10):1466-7.
2008: Steven A Kaplan; Alan J Wein; david staskin; Claus G Roehrborn; William D Steers
Urinary retention and post-void residual urine in men: separating truth from tradition.
The Journal of urology 2008;180(1):47-54.
2008: Roger R Dmochowski; Peter K Sand; Norman R Zinner; david staskin
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
Urology 2008;71(3):449-54.
2008: david staskin; M T Rosenberg; N V Dahl; P V Polishuk; Norman Zinner
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.
International journal of clinical practice 2008;62(1):27-38.
2007: david staskin; Peter Sand; Norman Zinner; Roger Dmochowski
Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
The Journal of urology 2007;178(3 Pt 1):978-83; discussion 983-4.
2007: M T Rosenberg; david staskin; S A Kaplan; Scott A MacDiarmid; D K Newman; Dana A Ohl
A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
International journal of clinical practice 2007;61(9):1535-46.
2007: david staskin; Edward Zoltan
Anticholinergics and central nervous system effects: are we confused?
Reviews in urology 2007;9(4):191-6.
2006: david staskin; Steven A Kaplan; Alan J Wein
Antimuscarinic therapy in men with bladder outlet obstruction.
Current urology reports 2006;7(6):437-9.
2006: david staskin
Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
The Urologic clinics of North America 2006;33(4):465-73, viii.
2006: Travis L Bullock; Gamal M Ghoniem; Carl G Klutke; david staskin
Advances in female stress urinary incontinence: mid-urethral slings.
BJU international 2006;98 Suppl 1():32-40; discussion 41-2.
2006: david staskin
Stimulating aspects of sacral nerve stimulation.
The Journal of urology 2006;175(6):1991-2.
2006: david staskin; Alexis E Te
Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
BJU international 2006;97(6):1256-61.
2006: Victor W Nitti; Steven Sanders; david staskin; Roger R Dmochowski; Peter K Sand; Scott A MacDiarmid; Howard I Maibach
Transdermal delivery of drugs for urologic applications: basic principles and applications.
Urology 2006;67(4):657-64.
2006: John Lavelle; Mickey M Karram; Franklin M Chu; Roger Dmochowski; Scott A MacDiarmid; david staskin; Peter K Sand; Rodney A Appell; Nurum Erdem
Management of incontinence for family practice physicians.
The American journal of medicine 2006;119(3 Suppl 1):37-40.
2006: david staskin; Scott A MacDiarmid
Pharmacologic management of overactive bladder: practical options for the primary care physician.
The American journal of medicine 2006;119(3 Suppl 1):24-8.
2006: david staskin; Scott A MacDiarmid
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
The American journal of medicine 2006;119(3 Suppl 1):9-15.
2006: M Slack; J S Sandhu; david staskin; R C Grant
In vivo comparison of suburethral sling materials.
International urogynecology journal and pelvic floor dysfunction 2006;17(2):106-10.
2005: Renuka Tyagi; david staskin
Mixed incontinence: the misclassification of patients and limitations of clinical trials.
Current urology reports 2005;6(6):424-8.
2005: Roger Dmochowski; david staskin
The Q-T interval and antimuscarinic drugs.
Current urology reports 2005;6(6):405-9.
2005: david staskin; Roger R Dmochowski; Alan J Wein
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
Current urology reports 2005;6(6):403-4.
2005: Roger Dmochowski; david staskin
Mixed incontinence: definitions, outcomes, and interventions.
Current opinion in urology 2005;15(6):374-9.
2005: Roger R Dmochowski; Victor W Nitti; david staskin; Karl Luber; Rodney A Appell; G Willy Davila
Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials.
World journal of urology 2005;23(4):263-70.
2005: Annabel Nixon; Shoshana Colman; Luann Sabounjian; Bobby Sandage; Ute E Schwiderski; david staskin; Norman Zinner
A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.
The Journal of urology 2005;174(2):604-7.
2005: david staskin; Alan Wein
Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?
Current medical research and opinion 2005;21(6):835-7.
2005: Norman Zinner; Mark Harnett; Luann Sabounjian; Bobby Sandage; Roger Dmochowski; david staskin
The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder.
The Journal of urology 2005;173(5):1639-43.
2005: david staskin
Overactive bladder in the elderly: a guide to pharmacological management.
Drugs & aging 2005;22(12):1013-28.
2004: david staskin; Mark D Harnett
Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder.
Current urology reports 2004;5(6):423-6.
2004: david staskin
The urge to define urgency: a review of three approaches.
Current urology reports 2004;5(6):413-5.
2003: Konstantin Walmsley; david staskin
Nocturia: when is it not related to overactive bladder?
Current urology reports 2003;4(6):441-5.
2003: Raymond W Pak; Steven P Petrou; david staskin
Trospium chloride: a quaternary amine with unique pharmacologic properties.
Current urology reports 2003;4(6):436-40.
2003: david staskin
Systematic review of anticholinergic agents: clinical trials versus clinical effectiveness.
Current urology reports 2003;4(6):419-20.
2003: Jennifer Tash; david staskin
Artificial graft slings at the midurethra: physiology of continence.
Current urology reports 2003;4(5):367-70.
2003: david staskin
Transdermal systems for overactive bladder: principles and practice.
Reviews in urology 2003;5 Suppl 8():S26-30.
2002: Roger R Dmochowski; david staskin
Advances in drug delivery: improved bioavailability and drug effect.
Current urology reports 2002;3(6):439-44.
2002: david staskin
Methodologic shortcomings inherent in a post-hoc analysis.
Current urology reports 2002;3(6):431-3.
2002: david staskin; Roger R Dmochowski
Future studies of overactive bladder: the need for standardization.
Urology 2002;60(5 Suppl 1):90-3.
2002: Roger R Dmochowski; david staskin
Overactive bladder in men: special considerations for evaluation and management.
Urology 2002;60(5 Suppl 1):56-62; discussion 62-3.
2002: david staskin; Alan J Wein; Karl Erik Andersson; Stuart B Bauer; Jerry G Blaivas; Kathryn L Burgio; Linda Cardozo; Christopher Chapple; Roger R Dmochowski; Suneel Gupta; Jacek L Mostwin; Joseph G Ouslander; Jeffrey P Weiss; Laura King
Overview consensus statement.
Urology 2002;60(5 Suppl 1):1-6.
2002: david staskin; Louis Plzak
Synthetic slings: pros and cons.
Current urology reports 2002;3(5):414-7.
2002: Kathleen Niknejad; Louis Plzak; david staskin; Kevin R Loughlin
Autologous and synthetic urethral slings for female incontinence.
The Urologic clinics of North America 2002;29(3):597-611.
2002: Louis Plzak; david staskin
Genuine stress incontinence theories of etiology and surgical correction.
The Urologic clinics of North America 2002;29(3):527-35.
2002: Roger Dmochowski; Sherron Kell; david staskin
Oxybutynin chloride: alterations in drug delivery and improved therapeutic index.
Expert opinion on pharmacotherapy 2002;3(4):443-54.
2001: Rodney A Appell; Peter Sand; Roger Dmochowski; R Anderson; Norman Zinner; D Lama; M Roach; J Miklos; D Saltzstein; T Boone; david staskin; D Albrecht
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Mayo Clinic proceedings. Mayo Clinic 2001;76(4):358-63.
2000: P M Sutaria; david staskin
Hydronephrosis and renal deterioration in the elderly due to abnormalities of the lower urinary tract and ureterovesical junction.
International urology and nephrology 2000;32(1):119-26.
1999: JM Choe; david staskin
Gore-Tex patch sling: 7 years later.
Urology 1999;54(4):641-6.
1999: JM Choe; ML Gallo; david staskin
A provocative maneuver to elicit cystometric instability: measuring instability at maximum infusion.
The Journal of urology 1999;161(5):1541-4.
1999: Peter K Sand; david staskin; J Miller; Ananias C Diokno; Grannum R Sant; G Willy Davila; P Knapp; S Rappaport; R Tutrone
Effect of a urinary control insert on quality of life in incontinent women.
International urogynecology journal and pelvic floor dysfunction 1999;10(2):100-5.
1998: J Jay; david staskin
Urinary Incontinence in Women.
Advance for nurse practitioners 1998;6(10):32-7.
1997: S W Siegel; D A Richardson; K L Miller; Mickey M Karram; N B Blackwood; P K Sand; david staskin; J P Tuttle
Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women.
Urology 1997;50(6):934-40.
1997: M Gallo; david staskin
Patient satisfaction with a reusable undergarment for urinary incontinence.
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society / WOCN 1997;24(4):226-36.
1997: ML Gallo; P J Fallon; david staskin
Urinary incontinence: steps to evaluation, diagnosis, and treatment.
The Nurse practitioner 1997;22(2):21-4, 26, 28 passim.
1997: JM Choe; david staskin
Artificial urinary sphincter: evolution and development.
Journal of long-term effects of medical implants 1997;7(1):75-100.
1997: JM Choe; david staskin
Clinical usefulness of urinary control urethral insert devices.
International urogynecology journal and pelvic floor dysfunction 1997;8(5):307-13.
1997: david staskin; JM Choe; D S Breslin
The Gore-tex sling procedure for female sphincteric incontinence: indications, technique, and results.
World journal of urology 1997;15(5):295-9.
1997: ML Gallo; david staskin
Cues to action: pelvic floor muscle exercise compliance in women with stress urinary incontinence.
Neurourology and urodynamics 1997;16(3):167-77.
1996: J P Norris; david staskin
History, physical examination, and classification of neurogenic voiding dysfunction.
The Urologic clinics of North America 1996;23(3):337-43.
1996: D A Richardson; K L Miller; S W Siegel; Mickey M Karram; N B Blackwood; david staskin
Pelvic floor electrical stimulation: a comparison of daily and every-other-day therapy for genuine stress incontinence.
Urology 1996;48(1):110-8.
1996: J P Norris; D S Breslin; david staskin
Use of synthetic material in sling surgery: a minimally invasive approach.
Journal of endourology / Endourological Society 1996;10(3):227-30.
1996: david staskin; T Bavendam; J Miller; G W Davila; A Diokno; P Knapp; S Rappaport; P Sand; G Sant; R Tutrone
Effectiveness of a urinary control insert in the management of stress urinary incontinence: early results of a multicenter study.
Urology 1996;47(5):629-36.
1995: Peter K Sand; D A Richardson; david staskin; Steven E Swift; R A Appell; K E Whitmore; D R Ostergard
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial.
American journal of obstetrics and gynecology 1995;173(1):72-9.
1995: A S Kibel; david staskin; V E Grigoriev
Intraperitoneal bladder rupture after normal vaginal delivery.
The Journal of urology 1995;153(3 Pt 1):725-7.
1995: C O Bruning; D S Breslin; Abraham Morgentaler; david staskin
Experience with the penile prosthesis and artificial urinary sphincter.
Journal of long-term effects of medical implants 1995;5(1):27-45.
1994: L A Kerr; S B Bauer; david staskin
Abnormal detrusor function precipitating hydronephrosis identified by extended voiding cystometry.
The Journal of urology 1994;152(1):89-92.
1991: david staskin
Hydroureteronephrosis after spinal cord injury. Effects of lower urinary tract dysfunction on upper tract anatomy.
The Urologic clinics of North America 1991;18(2):309-16.
1990: SG Mulholland; P Hanno; C L Parsons; G R Sant; david staskin
Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study.
Urology 1990;35(6):552-8.
1990: david staskin; A J Wein; K E Andersson
Urinary incontinence: classification and pharmacological therapy.
Ciba Foundation symposium 1990;151():289-306; discussion 306-17.
1989: Joseph G Ouslander; G Leach; david staskin; S Abelson; J Blaustein; L Morishita; Shlomo Raz
Prospective evaluation of an assessment strategy for geriatric urinary incontinence.
Journal of the American Geriatrics Society 1989;37(8):715-24.
1989: J G Ouslander; G E Leach; david staskin
Simplified tests of lower urinary tract function in the evaluation of geriatric urinary incontinence.
Journal of the American Geriatrics Society 1989;37(8):706-14.
1988: Joseph G Ouslander; G Leach; S Abelson; david staskin; J Blaustein; Shlomo Raz
Simple versus multichannel cystometry in the evaluation of bladder function in an incontinent geriatric population.
The Journal of urology 1988;140(6):1482-6.
1988: david staskin; Yoram Vardi; Mike B Siroky
Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control.
The Journal of urology 1988;140(1):117-8.
1988: david staskin; Ajay Nehra; Joseph G Ouslander
Urinary incontinence in the elderly.
Hospital practice (Office ed.) 1988;23(5A):133-4, 137-8, 140.
1987: Joseph G Ouslander; david staskin; Shlomo Raz; H L Su; K Hepps
Clinical versus urodynamic diagnosis in an incontinent geriatric female population.
The Journal of urology 1987;137(1):68-71.
1986: david staskin
Age-related physiologic and pathologic changes affecting lower urinary tract function.
Clinics in geriatric medicine 1986;2(4):701-10.
1986: david staskin; H R Hadley; P Zimmern; G E Leach; C P Schmidbauer; S Raz
Preoperative, intraoperative, and postoperative management of vaginal surgery.
Seminars in urology 1986;4(1):7-12.
1986: C P Schmidbauer; H Hadley; david staskin; P Zimmern; G E Leach; S Raz
Complications of vaginal surgery.
Seminars in urology 1986;4(1):51-62.
1986: P Zimmern; G E Leach; H R Hadley; C P Schmidbauer; david staskin; S Raz
Transvaginal closure of the bladder neck.
Seminars in urology 1986;4(1):30-2.
1986: P Zimmern; C P Schmidbauer; G E Leach; david staskin; H R Hadley; S Raz
Vesicovaginal and urethrovaginal fistulae.
Seminars in urology 1986;4(1):24-9.
1986: david staskin; H R Hadley; G E Leach; C P Schmidbauer; P Zimmern; S Raz
Anatomy for vaginal surgery.
Seminars in urology 1986;4(1):2-6.
1986: G E Leach; P Zimmern; david staskin; C P Schmidbauer; H R Hadley; S Raz
Surgery for pelvic prolapse.
Seminars in urology 1986;4(1):43-50.
1986: H R Hadley; david staskin; C P Schmidbauer; P Zimmern; G E Leach; S Raz
Operative correction for female urethral incompetence.
Seminars in urology 1986;4(1):13-23.
1986: G E Leach; C P Schmidbauer; H R Hadley; david staskin; P Zimmern; S Raz
Surgical treatment of female urethral diverticulum.
Seminars in urology 1986;4(1):33-42.
1986: P E Zimmern; david staskin; S Raz
[Urethral replacement in women. Experimental works and clinical application].
Journal d'urologie 1986;92(5):281-4.
1985: david staskin; Joseph G Ouslander; Shlomo Raz
Office evaluation of female urinary incontinence.
Primary care 1985;12(4):675-85.
1985: david staskin; T Malloy; V Carpiniello; I Schwartz; A Wein
Urological complications secondary to a contraceptive diaphragm.
The Journal of urology 1985;134(1):142-3.
1985: david staskin; S Raz
Urology: needle urethral-vesical suspensions for stress incontinence.
The Western journal of medicine 1985;142(6):823-4.
1985: david staskin; P E Zimmern; H R Hadley; S Raz
Pathophysiology of stress incontinence.
Clinics in obstetrics and gynaecology 1985;12(2):357-68.
1985: H R Hadley; P E Zimmern; david staskin; S Raz
Transvaginal needle bladder neck suspension.
Clinics in obstetrics and gynaecology 1985;12(2):497-514.
1985: P E Zimmern; H R Hadley; david staskin; S Raz
Genitourinary fistulas: vaginal approach for repair of vesicovaginal fistulas.
Clinics in obstetrics and gynaecology 1985;12(2):403-13.
1985: david staskin; P E Zimmern; H R Hadley; S Raz
The pathophysiology of stress incontinence.
The Urologic clinics of North America 1985;12(2):271-8.
1985: P E Zimmern; H R Hadley; david staskin; S Raz
Genitourinary fistulae. Vaginal approach for repair of vesicovaginal fistulae.
The Urologic clinics of North America 1985;12(2):361-7.
1985: H R Hadley; P E Zimmern; david staskin; S Raz
Transvaginal needle bladder neck suspension.
The Urologic clinics of North America 1985;12(2):291-303.
1983: R M Levin; david staskin; A J Wein
Analysis of the anticholinergic and musculotropic effects of desmethylimipramine on the rabbit urinary bladder.
Urological research 1983;11(6):259-62.
1981: david staskin; K F Parsons; R M Levin; A J Wein
Bladder transection--a functional, neurophysiological, neuropharmacological and neuroanatomical study.
British journal of urology 1981;53(6):552-7.
1981: david staskin; K F Parsons; R M Levin; A J Wein
A new technique for chronic catheterization of female dogs.
Investigative urology 1981;19(2):109-19.